English
PD-1 / NFAT Reporter - Jurkat Recombinant Cell Line
PD-1 / NFAT Reporter - Jurkat Recombinant Cell Line
Artikelnummer
BPS60535
Verpackungseinheit
2 vials
Hersteller
BPS Bioscience
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Products from BPS Bioscience require a minimum order value above 400€
Applications: Screen for activators or inhibitors of PD-1 signaling in a cellular context Characterize the biological activity of PD-1 and its interactions with ligands
Background: The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated Tcells,to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity andallows cancer cells to escape immune surveillance. The PD-1:PD-L1/2 pathway is also involvedin regulating autoimmune responses, making these proteins promising therapeutic targets for anumber of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes.
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #NM_005018).
Format: Aqueous solution containing DMSO
Genbank: NM_005018
Host Cell Line: Jurkat
Mycoplasma Testing: The cell line has been screened using the PCR-based Venor™GeM Mycoplasma Detection kit (Sigma-Aldrich) to confirm the absence of Mycoplasma species.
Storage Stability: Immediately upon receipt, store in liquid nitrogen.
Supplied As: Each vial contains 2 X 106 cells in 1 ml of 10% DMSO
Warnings: Avoid freeze/thaw cycles.
Biosafety Level: BSL-1
Applications: Screen for activators or inhibitors of PD-1 signaling in a cellular context Characterize the biological activity of PD-1 and its interactions with ligands
Background: The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated Tcells,to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity andallows cancer cells to escape immune surveillance. The PD-1:PD-L1/2 pathway is also involvedin regulating autoimmune responses, making these proteins promising therapeutic targets for anumber of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes.
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #NM_005018).
Format: Aqueous solution containing DMSO
Genbank: NM_005018
Host Cell Line: Jurkat
Mycoplasma Testing: The cell line has been screened using the PCR-based Venor™GeM Mycoplasma Detection kit (Sigma-Aldrich) to confirm the absence of Mycoplasma species.
Storage Stability: Immediately upon receipt, store in liquid nitrogen.
Supplied As: Each vial contains 2 X 106 cells in 1 ml of 10% DMSO
Warnings: Avoid freeze/thaw cycles.
Biosafety Level: BSL-1
| Artikelnummer | BPS60535 |
|---|---|
| Hersteller | BPS Bioscience |
| Hersteller Artikelnummer | 60535 |
| Verpackungseinheit | 2 vials |
| Mengeneinheit | PAK |
| Wirt | Human |
| Produktinformation (PDF) | Download |
| MSDS (PDF) |
|
Verwandte Artikel
Markieren Sie die Artikel, um Sie dem Warenkorb hinzuzufügen oder
Immer für Sie da
Gernot Ensinger, M.Sc.
Laurent Haze
